Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Parkinson’s Disease

Recent news which mentions Parkinson’s Disease

Edward L. Weidenfeld, Reagan Attorney & DC Socialite Who Went From Capitol Hill To Cannabis Entrepreneur Dies At 79
Tags News Edward L/ Weidenfeld Parkinson’s Disease
From Benzinga
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
Tickers PHRRF
Tags Psychedelics Cannabis Market News
From Benzinga
AbbVie Walks Away From Parkinson's Drug Pact With BioArctic
Tickers ABBV
Tags Parkinson’s Disease Market News Benzinga
From Benzinga
Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program
Tickers GANX
Tags why it's moving Briefs News
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags General Briefs News
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
Tickers GANX
Tags Briefs News Movers
From Benzinga
4D Pharma To Test Its Single-Strain Live Biotherapeutics In Parkinson's Disease
Tickers LBPS
Tags Penny Stocks Trading Ideas FDA
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags General Health Care Phase 3 Trial
From Benzinga
Yumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Disease
Tickers YMTX
Tags Biotech YMTX Health Care
From Benzinga
Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data
Tickers YMTX
Tags Biotech Phase 1 Trial YMTX
From Benzinga
Why Did BioVie Shares Jump 21% Today?
Tickers BIVI
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags Market News Parkinson’s Disease Phase 2 Trial
From Benzinga
Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate
Tickers IKT
Tags Biotech Health Care Preclinical Phase
From Benzinga
Stealth Bio Posts Encouraging Preclinical Data In Parkinson's Animal Studies
Tickers MITO
Tags News Briefs Biotech
From Benzinga
Gain Therapeutics' Gaucher, Parkinson's Candidate Shows Potential In Patient-Derived iPSC Study
Tickers GANX
Tags Health Care GANX Biotech
From Benzinga
Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial
Tickers AMRX
Tags Benzinga Trading Ideas Parkinson’s Disease
From Benzinga
AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration
Tickers ABBV
Tags ABBV General Health Care
From Benzinga
Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis
Tickers CLNN
Tags News Briefs Movers
From Benzinga
IBM, Michael J. Fox Foundation Using Artificial Intelligence To Fight Parkinson's Disease
Tickers IBM TECH
Tags News General Top Stories
From Benzinga
AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate
Tickers ACIU BNTX
Tags News Briefs General
From Benzinga
Inhibikase To Start Testing Its Parkinson's Candidate In Patients
Tickers IKT
Tags Briefs News Biotech
From Benzinga
Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med
Tickers ACOR
Tags ACOR General Movers
From Benzinga
Ipsen In-Licenses Parkinson's Candidate From IRLAB
Tickers IPSEY
Tags IPSEY Health Care General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.